249 related articles for article (PubMed ID: 26116776)
1. ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway.
Yu T; Chen C; Sun Y; Sun H; Li TH; Meng J; Shi X
Biochem Biophys Res Commun; 2015 Aug; 464(1):286-91. PubMed ID: 26116776
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening.
Qiu Y; Yu T; Wang W; Pan K; Shi D; Sun H
Biochem Biophys Res Commun; 2014 May; 448(1):15-21. PubMed ID: 24735534
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.
Kai S; Lu JH; Hui PP; Zhao H
Biochem Biophys Res Commun; 2014 Sep; 452(3):768-74. PubMed ID: 25201730
[TBL] [Abstract][Full Text] [Related]
4. P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.
Zhen YF; Wang GD; Zhu LQ; Tan SP; Zhang FY; Zhou XZ; Wang XD
J Cell Physiol; 2014 Oct; 229(10):1475-83. PubMed ID: 24615518
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
6. The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.
Wroblewski D; Mijatov B; Mohana-Kumaran N; Lai F; Gallagher SJ; Haass NK; Zhang XD; Hersey P
Carcinogenesis; 2013 Feb; 34(2):237-47. PubMed ID: 23087082
[TBL] [Abstract][Full Text] [Related]
7. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.
Lucas KM; Mohana-Kumaran N; Lau D; Zhang XD; Hersey P; Huang DC; Weninger W; Haass NK; Allen JD
Clin Cancer Res; 2012 Feb; 18(3):783-95. PubMed ID: 22173547
[TBL] [Abstract][Full Text] [Related]
8. BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis.
Miller LA; Goldstein NB; Johannes WU; Walton CH; Fujita M; Norris DA; Shellman YG
J Invest Dermatol; 2009 Apr; 129(4):964-71. PubMed ID: 18987671
[TBL] [Abstract][Full Text] [Related]
9. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
10. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
11. Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad.
Yin S; Dong Y; Li J; Fan L; Wang L; Lu J; Vang O; Hu H
Apoptosis; 2012 Apr; 17(4):388-99. PubMed ID: 22179721
[TBL] [Abstract][Full Text] [Related]
12. Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens.
Anvekar RA; Asciolla JJ; Lopez-Rivera E; Floros KV; Izadmehr S; Elkholi R; Belbin G; Sikora AG; Chipuk JE
Cell Death Dis; 2012 Nov; 3(11):e420. PubMed ID: 23152056
[TBL] [Abstract][Full Text] [Related]
13. CypD-mPTP axis regulates mitochondrial functions contributing to osteogenic dysfunction of MC3T3-E1 cells in inflammation.
Gan X; Zhang L; Liu B; Zhu Z; He Y; Chen J; Zhu J; Yu H
J Physiol Biochem; 2018 Aug; 74(3):395-402. PubMed ID: 29679227
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
[TBL] [Abstract][Full Text] [Related]
15. GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.
Zheng L; Yang W; Zhang C; Ding WJ; Zhu H; Lin NM; Wu HH; He QJ; Yang B
Cancer Lett; 2011 Oct; 309(1):27-36. PubMed ID: 21664043
[TBL] [Abstract][Full Text] [Related]
16. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA.
Keuling AM; Andrew SE; Tron VA
Pigment Cell Melanoma Res; 2010 Jun; 23(3):430-40. PubMed ID: 20337986
[TBL] [Abstract][Full Text] [Related]
18. ABT-737 accelerates butyrate-induced death of HL-60 cells. Involvement of mitochondrial apoptosis pathway.
Stefaniková A; Kliková K; Hatok J; Račay P
Gen Physiol Biophys; 2013 Dec; 32(4):505-16. PubMed ID: 23940089
[TBL] [Abstract][Full Text] [Related]
19. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo.
Dong YY; Zhuang YH; Cai WJ; Liu Y; Zou WB
Tumour Biol; 2016 Nov; 37(11):15053-15063. PubMed ID: 27658776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
